- Home
- PROK vs NAUT Comparison
PROK vs NAUT Comparison
Compare PROK & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- NAUT
- Stock Information
- Founded
- PROK 2015
- NAUT 2016
- Country
- PROK United States
- NAUT United States
- Employees
- PROK N/A
- NAUT N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- PROK Health Care
- NAUT Industrials
- Exchange
- PROK Nasdaq
- NAUT Nasdaq
- Market Cap
- PROK 85.5M
- NAUT 94.9M
- IPO Year
- PROK N/A
- NAUT N/A
- Fundamental
- Price
- PROK $3.27
- NAUT $0.73
- Analyst Decision
- PROK Buy
- NAUT Strong Sell
- Analyst Count
- PROK 5
- NAUT 1
- Target Price
- PROK $6.25
- NAUT $1.75
- AVG Volume (30 Days)
- PROK 37.1M
- NAUT 530.5K
- Earning Date
- PROK 08-08-2025
- NAUT 07-31-2025
- Dividend Yield
- PROK N/A
- NAUT N/A
- EPS Growth
- PROK N/A
- NAUT N/A
- EPS
- PROK N/A
- NAUT N/A
- Revenue
- PROK $306,000.00
- NAUT N/A
- Revenue This Year
- PROK $85.21
- NAUT N/A
- Revenue Next Year
- PROK N/A
- NAUT N/A
- P/E Ratio
- PROK N/A
- NAUT N/A
- Revenue Growth
- PROK N/A
- NAUT N/A
- 52 Week Low
- PROK $0.46
- NAUT $0.66
- 52 Week High
- PROK $7.13
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- PROK 62.08
- NAUT 48.69
- Support Level
- PROK $3.17
- NAUT $0.71
- Resistance Level
- PROK $4.05
- NAUT $0.77
- Average True Range (ATR)
- PROK 1.00
- NAUT 0.06
- MACD
- PROK 0.13
- NAUT -0.00
- Stochastic Oscillator
- PROK 43.10
- NAUT 30.81
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.